InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Duker Jay S., Chief Executive Officer. Director active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 3 disclosures have been logged. The latest transaction was filed on 22 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations3 total
040,000 shares0
Common Stock
SEC:0001485003-22-000085:0·
04,966 shares0
Common Stock
SEC:0001562180-22-001414·
04,966 shares0
Common Stock
SEC:0001562180-22-001414:0·
3 of 3 declarations
About Duker Jay S.
Jay S. Duker is the Chief Operating Officer and Board Member of EyePoint Pharmaceuticals, Inc. and Sesen Bio, Inc. In this role, he oversees the operations of both companies and contributes to strategic direction. His experience in the pharmaceutical sector is essential in guiding growth and innovation within these organizations. He plays a key role in decision-making that impacts the performance of the companies.
